Background: Nowadays, cardiovascular disease is considered as a leading cause of mortality worldwide, and dyslipidemia is one of its most common risk factors. Moreover, most of the ischemic heart diseases are said to be secondary to dyslipidemia and its effects. Dyslipidemia with a high prevalence has been the subject of multiple studies. As a family physician, the role of identification of people with this major risk factor has gained importance, especially with availability of screening and management. Objectives: In this study, we aim to provide summarized, yet comprehensive review focusing on screening, diagnosis and management of dyslipidemia. Methodology: PubMed database was used for articles selection using particular keywords. Conclusion: Dyslipidemia recognition, management and guidelines are ever changing with the recent breakthroughs. Thus, primary health care physicians shall be aware of the recent protocols regarding the screening of the population, diagnosis, management and especially follow-up. Moreover, family physician has to ensure the compliant of the patient in order to have the best outcome in these cases. Nevertheless, further studies with larger sample sizes and better design are necessary to establish the full effect of the recent drugs, which may change the way we approach this disease.
Copyright © 2024 Archives of Pharmacy Practice. Authors retain copyright of their article if they are accepted for publication.
Developed by Archives of Pharmacy Practice